Cardiac Success

The company develops the Vsling, a transcatheter ventricular repair device designed to treat patients with Heart Failure with Reduced Ejection Fraction (HFrEF). The system directly reshapes the dilated left ventricle to halt deterioration and initiate heart recovery by cinching the papillary muscle bases. The procedure serves as a minimally invasive alternative to surgical ventricular remodeling for symptomatic patients who have limited treatment options.